Feb 2013 $1 M No. 5 Under $2 million 10
Nuclea Biotechnologies, LLC: Raise no. 5, Feb 2013 × Investors in this round 10 investors had bought by the notice of Feb 20, 2013: 10 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $1 M (amount offered: indefinite)
Smallest investment taken no minimum stated
What was sold equity
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Patrick J. Muraca · Executive Officer, Director Paula J. Evans · Executive Officer Robert J. Pierce · Executive Officer Charles P. Stetson · Director Richard R. Vietor · Director William R. Harman · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Paula C. Evans, Secretary. Source: SEC Form D, newest notice filed Feb 20, 2013. Read the notice at the SEC .
equity SEC Jul 2012 $5 M No. 4 $2 to $10 million 30
Nuclea Biotechnologies, LLC: Raise no. 4, Jul 2012 × Investors in this round 30 investors had bought by the notice of Aug 8, 2012: 30 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $5 M (amount offered: indefinite)
Smallest investment taken no minimum stated
What was sold equity
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Patrick J. Muraca · Executive Officer, Director Paula J. Evans · Executive Officer Robert J. Pierce · Executive Officer Charles P. Stetson · Director Richard R. Vietor · Director William R. Harman · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Paula C. Evans, Secretary. Source: SEC Form D, newest notice filed Aug 8, 2012. Read the notice at the SEC .
equity SEC Mar 2012 $2 M No. 3 Under $2 million 15
Nuclea Biotechnologies, LLC: Raise no. 3, Mar 2012 × Investors in this round 15 investors had bought by the notice of Apr 11, 2012: 15 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $2 M (amount offered: indefinite)
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities, securities to be acquired by exercising them
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people $56,933 (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Patrick J. Muraca · Executive Officer, Director Paula J. Evans · Executive Officer Robert J. Pierce · Executive Officer Charles P. Stetson · Director Richard R. Vietor · Director William R. Harman · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the use of proceeds: “This portion of the gross proceeds of the offering was used to repay the debt to one of the officers of the Issuer.”Signed by Paula C. Evans, Secretary. Source: SEC Form D, newest notice filed Apr 11, 2012. Read the notice at the SEC .
equity, options SEC Aug 2011 $3 M No. 2 $2 to $10 million 28
Nuclea Biotechnologies, LLC: Raise no. 2, Aug 2011 × Investors in this round 28 investors had bought by the notice of Aug 18, 2011: 28 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $3 M (amount offered: indefinite)
Smallest investment taken no minimum stated
What was sold equity
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Patrick J. Muraca · Executive Officer, Director Paula J. Evans · Executive Officer Robert J. Pierce · Executive Officer Charles P. Stetson · Director Dennis K. Stone · Director Richard R. Vietor · Director William R. Harman · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Paula C. Evans, Secretary. Source: SEC Form D, newest notice filed Aug 18, 2011. Read the notice at the SEC .
equity SEC Jun 2009 $9 M No. 1 $2 to $10 million 27
Nuclea Biotechnologies, LLC: Raise no. 1, Jun 2009 × Investors in this round 27 investors had bought by the notice of Nov 1, 2010: 27 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $9 M (amount offered: indefinite)
Smallest investment taken no minimum stated
What was sold equity
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Limited Liability Company, incorporated in Delaware People named in the notice Patrick J. Muraca · Executive Officer, Director Paula C. Evans · Executive Officer James W. Lewis · Director Richard R. Vietor · Director William R. Harman · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Patrick J. Muraca, President & CEO. Source: SEC Form D and 2 amendments, newest notice filed Nov 1, 2010. Read the notice at the SEC .
equity SEC